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from the Indian subcontinent - a blinded,
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Abstract
Background: Coronary heart disease (CHD) is highly prevalent amongst the South Asian communities in Britain.
The reasons for this excess CHD risk are multifactorial, but in part relate to a susceptibility to diabetes mellitus -
where the aberrant metabolism of non-esterified fatty acids (NEFA) and glucose are likely to underpin vascular
disease in this population. Dietary intervention is an important and first line approach to manage increased CHD
risk. However, there is limited information on the impact of the South Asian diet on CHD risk.
Methods/Design: The Diabetes Health, Residence & Metabolism in Asians (DHRMA) study is a blinded,
randomised, placebo controlled trial that analyses the efficacy of reduced glycaemic index (GI) staples of the South
Asian diet, in relation to cardio-metabolic risk factors that are commonly perturbed amongst South Asian
populations - primarily glucose, fatty acid and lipoprotein metabolism and central adiposity. Using a 10-week
dietary intervention study, 50 healthy South Asians will be randomised to receive either a DHRMA (reduced GI)
supply of chapatti (bread), stone ground, high protein wheat flour and white basmati rice (high bran, unpolished)
or commercially available (leading brand) versions chapatti wheat flour and basmati rice. Volunteers will be asked
to complete a 75g oral glucose tolerance test at baseline and at 10-weeks follow-up, where blood metabolites and
hormones, blood pressure and anthropometry will also be assessed in a standardised manner.
Discussion: It is anticipated that the information collected from this study help develop healthy diet options
specific (but not exclusive) for South Asian ethnic communities.
Trial registration
Current Controlled Trials ISRCTN02839188
Background
Coronary heart disease (CHD) is the leading cause of
mortality and morbidity amongst South Asians living in
the UK (people originating from the Indian subconti-
nent), who have a 50% greater risk of dying prematurely
from this affliction than the general population [1,2].
This increased CHD risk is multifactorial, but in part is
likely to be influenced by diabetes mellitus [3], which is
more common amongst South Asian groups [4]. Indeed,
CHD risk in South Asians is coordinated with the fre-
quent clustering of metabolic risk factors that includes
aberrant glucose and lipid metabolism[5,6], which may
represent the commonality between diabetogenesis and
atherogenesis in this population. These metabolic risk
factors are recognised to be associated with more
advanced atherosclerotic vascular disease [7] and
increased cardiovascular mortality [8,9].
There is an urgent need for effective ‘targeted’
approaches in the prevention and management of CHD
and the associated metabolic risk in South Asians. Diet-
ary intervention remains a ‘first line’ approach to man-
age this increased risk. While dietary health promotion
approaches to the management and prevention of CHD
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is availible for South Asians (i.e diet leaflets and health
DVDs, websites such as South Asian health [10]), much
of the scientific evidence that such material is based
upon uses findings in populations other than South
Asians. For South Asian diabetics, general health pro-
motion material has had limited impact [11]. South
Asians have also been excluded from major diabetes and
cardiovascular clinical trials [12]. Reasons for this are
complex, and it is not clear what the range of contribu-
tory factors are, what are the main reasons and whether
the real issue is one of ‘planned exclusion’, ‘inadvertent
exclusion’, ‘non-participation’ or a mixture of these.
There is a need to increase South Asian participation in
research.
Dietary transition and cardiovascular risk in South Asians
The present study [DHRMA] was specifically developed
to advance findings from an epidemiological study of
CHD risk in a population of Indian migrants living in
the UK. In this study, nutritional intake, lifestyle, glu-
cose tolerance and CHD risk were compared between
Indians living in Sandwell (UK) and their contempor-
aries still living in villages of origin in rural India [13].
While diabetes prevalence was generally high (15% irre-
spective of site), in India it was less frequently accompa-
nied by metabolic CHD risk factors such as raised
triglycerides and central obesity. The greater metabolic-
CHD risk amongst the migrant Indians was under-
pinned by dietary change, a transition towards higher
energy and fat intake at the expense of carbohydrate.
Data also suggested a background of higher glucose
excursions and unregulated NEFA metabolism in Indian
populations [14], which has been reported elsewhere as
ethnic differences in NEFA profiles following oral glu-
cose challenges [15]. NEFA metabolism may be a key
driver for the major CHD risk of these communities,
through its role on lipid metabolism and hepatic insulin
resistance [16].
Glycaemic index in South Asian foods
Reducing postprandial glucose and NEFA concentra-
tions may be a desirable option in the dietary manage-
ment of metabolic-CHD risk in South Asians [17]. In
recent years the ‘glycaemic index’ (GI) (a ranking system
for carbohydrates based on their immediate effect on
blood glucose levels) has emerged as a classification sys-
tem for carbohydrate-containing food, where consump-
tion of high GI meals in comparison with energy- and
nutrient-controlled low GI foods are adversely asso-
ciated with glucose intolerance [18]. The GI of foods
relates to the nature of monosaccharides, starches, fat,
protein and fibre it contains, and the method with
which it is cooked. Typically, stone-ground breads have
a low GI (high protein and fibre), which is why stone-
ground chapatti flour is also likely to have a low GI,
compared to other more refined versions (devoid of
bran). Basmati rice has a high amylase content, which
confers a low GI, and a higher bran content is likely to
lower GI further, especially in an unpolished (i.e. high
bran) preparation. Importantly, low GI foods are shown
to reduce hyperglycaemia, hyperinsulinaemia and post-
prandial circulating NEFA [19]. While South Asians
resident in Britain have varied diets (influenced by cul-
ture, religion and British culture), many migrants still
subscribe to diets that include staples of carbohydrate
such as breads (chapatti, roti, naan) and rice [20]. The
industrialisation of food processing and relative afflu-
ence has promoted the consumption of more refined
foods (high GI) both in India and the UK. In South
India [21], postprandial glucose excursions were favour-
ably delayed by staple foods prepared and eaten there,
but these foods have yet to be assessed in Britain
amongst Indian migrant populations.
Objectives and hypothesis of DHRMA
The purpose of DHRMA is to provide the scientific
basis to help regenerate cultural traditions in food
intake, with the aim to develop dietary CHD manage-
ment options, specifically tailored (but not exclusively)
for people of South Asian origin living in the UK.
DHRMA is a novel project, as these foods are not com-
mercially available, and the study plan is based on pilot
findings from our own research and developed with
experience from our ongoing programme of CHD risk
screening in ethnic minorities (Healthy Hearts), where
900 individuals have been assessed using a community
based approach. [22]
Objectives are as follows
(i) to establish the GI of existing (ie. produced in the
UK) traditional, and regenerated (see (ii)) food sta-
ples of South Asian cuisine (specifically chapatti
flour and basmati rice).
(ii) to develop will DHRMA test foods that have
been specifically that are processed in a similar fash-
ion to those available in rural India: basmati rice
that is polished to a low level (less bran removed,
grain quality distribution ratio score by KETT
(Tokyo, Japan) of <35%)*, and stone-ground chapatti
flour with added grains (oats, barley and chick pea).
(iii)to determine the efficacy of low GI DHRMA
foods on indices of diabetes and CHD risk using a
blinded, randomised controlled trial.
Note* KETT is an industry standard originating from
Japan - a score based on the whiteness of rice. Generally
amongst basmati rice sold in the UK, this score is
around 40-44%.
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The DHRMA study will focus on testing the hypoth-
esis that a 10-week supply of DHRMA foods (reduced
GI supply of chapatti stone ground, high protein wheat
flour and high bran, unpolished white basmati rice) to
healthy South Asians will result in favourable changes in
cardio-metabolic risk factors (glucose tolerance, fatty
acid, triglyceride and HDL cholesterol metabolism and
central adiposity) as compared those randomised to
commercially popular (market leaders) versions of cha-
patti flour and white basmati rice.
Methods/Design
Ethical approval for the study was provided by North
Staffordshire Research Ethics Committee (REC reference
08/H1204/130), and all prospective volunteers for the
DHRMA study will undergo an informed consent pro-
cess. The DHRMA study is split into two parts, (i) the
assessment of glycaemic index in Indian foods and (ii) a
dietary intervention trial.
Development of DHRMA low glycaemic index foods
The Study will be undertaken in the area of Sandwell
and West Birmingham, at Sandwell and West Birming-
ham Hospitals NHS trust (UK). Healthy volunteers
(body mass-index between 18-25 kg/m2, no known car-
diovascular disease or associated medication, normal
glucose tolerance) will be approached for this study
from local communities [22] as well as hospital staff.
The GI will be measured using FAO/WHO expert con-
sultation (1998) guidelines. Briefly, an eight point capil-
lary blood glucose profile will be measured over a 2
hour period (i.e. 15 min intervals) following the admin-
istration of a 50 g glucose load in each prospective
volunteer after an overnight fast. Volunteers will then
be invited for repeat visits where a 50 g glucose equiva-
lent from test foods will be administered (done in tripli-
cate for as recommended by the FAO/WHO guidelines).
The preparation of chapattis (ingredients, size and
cooking time) and rice (water added and cooking time)
will be standardised by researchers and subjects will be
advised a standard level of activity during the study per-
iod. The test foods will be eaten over 15 minutes with
water. Capillary blood samples will be analysed using a
standard capillary glucose monitor (quality assurance
monitored, Roche Accutrend GC, Roche UK). A capil-
lary blood glucose response for curve for each test food
will be plotted, and with each subject, the GI for the
food will be the proportion of this area as a percentage
of the response to 50 g of glucose.
Interventional trial
This is a 10-week, blinded, parallel, randomised inter-
vention trial in South Asians either DHRMA versions of
stone ground chapatti flour and high bran white Basmati
rice or the commercially popular white chapatti flour
(Elephant atta, Premier Foods, UK) and white Basmati
(Tilda, UK) will be supplied to participants.
The Inclusion criteria will include age <55 yrs, BMI
<30 kg/m2, systolic/diastolic BP <140/90 mmHg (no
antihypertensive use), South Asian ethnicity and use of
chapatti flour or rice as part of their normal diet (>3
times a week) and >50% of energy derived from carbo-
hydrates and <30% from fat - determined by 4-day food
diaries, used previously [13]).
A total of 50 subjects will be randomised onto either
arm in a blinded fashion, and supplied with study carbo-
hydrates (see Figure 1). The study carbohydrates will be
packaged by our industrial collaborator (East End Foods,
UK), who randomise and allocate individual packet
numbers to each test food (information relating to the
contents will be stored with our collaborator and so
blinded to study researchers and the study participants).
The supply of rice and flour will be in clear, unlabelled
15 kg bags packaged within a white box with an
assigned randomisation number and trial details. Ran-
dom number allocation will be through a computer gen-
erated system, with no provision for factorisation.
Each participant will be asked to attend three visits
(screen, randomisation and follow-up). The screening
visit will be used to initiate the consent process blood,
and to assess inclusion criteria (eg dietary intake).
At randomisation and follow-up, blood pressure and
anthropometry will be measured and an OGTT will be
performed. Subjects will also be asked to complete a 4-
day dietary record at randomisation and follow-up. The
main metabolic measures will be 10 week changes in -
OGTT metabolites and hormones (glucose, insulin,
NEFA), adiponectin, leptin and lipids and lipoproteins
(including serum triglycerides and HDL cholesterol).
Power calculation
The sample size was calculated on the results from our
migration study [13] and dietary intervention study [23]
where we found a 0.56 (SD = 0.34) fall in CHD risk
using the biomarker C-reactive protein for individuals
on the substitution dietary intervention and no signifi-
cant reduction in the other groups. Using a paired t-
test, at 80% power, a<0.05, 25 subjects/arm will allow
the detection of a 1 mmol difference in 2 hr glucose
and 0.15 mmol change in NEFA suppression (this is ½
the difference seen between glucose tolerant and intoler-
ant Indian Gujaratis in our migration study [14]).
Discussion
The DHRMA study aims to investigate key staples in
the South Asian diet and provides the basis for cultu-
rally specific dietary options for the management of
CHD risk, in addition to a better understanding of the
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cardiovascular-metabolic risk in this group. The research
focuses on the efficacy of low glycaemic index foods,
which have been shown to be beneficial in relation to
metabolic processes, and specifically, those that are
reported to contribute to cardiovascular risk amongst
South Asian populations.
The DHRMA study makes the assumption that it is the
quality of carbohydrate that influences cardiovascular
Figure 1 Study Flow-chart.
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risk in South Asians. From our previous work we
observed that it was a transition from a diet high in car-
bohydrates to one with reduced energy from carbohy-
drates that promoted an adverse risk in South Asians
[13]. However, we were not able to analyse the quality of
the carbohydrate. Some key nutritional deficiencies have
been highlighted for this population, which are not under
investigation in the current study. For example, South
Asians living in Britain also have both lower and altered
vitamin D metabolism [24,25], which is consistent with
observations amongst migrant South Asians elsewhere
[26]. Long chain omega-3 fatty acids (Omega-3 PUFA)
are accepted as a treatment for hypertriglyceridaemia and
provide protection against CHD [27,28]. Low levels of
omega-3 fattys acids have been consistently reported as a
risk factor of CHD in South Asians living in urban, rural
and UK settings [29-32].
By using foods from the Indian subcontinent, the
DHRMA study aims to regenerate traditions in diet,
likely to be effective in elderly South Asians, and will
also provide an additional management angle for clini-
cians. Hence, the data will provide an evidence base for
a ‘tailored approach’ to cardiovascular risk management
in this high risk population.
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